Collegium 製藥公司
US ˙ NasdaqGS ˙ US19459J1043

SecurityCOLL / Collegium Pharmaceutical, Inc.
InstitutionJefferies Group LLC
Latest Disclosed Ownership21,250 shares
Latest Disclosed Value $ 340,425
Jefferies Group LLC ownership in COLL / Collegium Pharmaceutical, Inc.

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 21,250 shares of Collegium Pharmaceutical, Inc. (US:COLL) valued at $340,425 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 15, 2022 disclosing 12,413 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 71.19% during the quarter. The current value of the position is $709,325 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (COLL) in the form of stock options. The firm currently holds call options representing 41,500 of underlying shares valued at $664,830 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

COLL / Collegium Pharmaceutical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 21,250 8,837 71.19 340 1,207.69 0.0028
2022-11-14 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 21,250 8,837 340 0.0027
2022-08-15 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 12,413 12,413 26 0.0002
2023-09-21 2022-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -160,885 -100.00 0 -100.00
2022-05-16 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -160,885 0
2023-09-21 2021-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 160,885 160,885 3,005 0.0176
2022-02-14 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 160,885 160,885 3,005 0.0161
2023-09-21 2021-06-30 13F/A-2 COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -6,500 -100.00 0 -100.00
2021-08-20 2021-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -6,500 0
2021-08-16 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -6,500 0
2023-09-21 2021-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 6,500 3,927 152.62 154 201.96 0.0014
2021-05-14 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 6,500 3,927 154 0.0013
2023-09-21 2020-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 2,573 2,573 52 0.0004
2021-02-16 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 2,573 2,573 52 0.0005
2019-02-14 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -18,405 -100.00 0 -100.00
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,405 18,405 271 0.0018
2018-08-14 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -9,100 -100.00 0 -100.00
2018-05-15 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 9,100 -39,300 -81.20 233 -73.91 0.0013
2018-02-14 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 48,400 48,400 431.87 893 283.26 0.0042
2017-08-14 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -15,000 -100.00 0 -100.00
2017-05-15 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,000 -60,811 -80.21 151 -87.20 0.0011
2017-02-14 2016-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 75,811 75,811 1,180 0.0066
2017-02-14 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 75,811 1,180 0.0066
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A COLLEGIUM PHARMACEUTICAL COM Call 41,500 665 n/a n/a n/a
2022-11-14 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM Call 41,500 665 n/a n/a n/a
2021-08-20 2021-06-30 13F/A COLLEGIUM PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2023-09-21 2021-06-30 13F/A COLLEGIUM PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM Call 0 0 n/a n/a n/a
2023-09-21 2021-03-31 13F/A COLLEGIUM PHARMACEUTICAL COM Call 12,500 0.00 296 18.40 n/a n/a n/a
2021-05-14 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM Call 12,500 296 n/a n/a n/a
2023-09-21 2020-12-31 13F/A COLLEGIUM PHARMACEUTICAL COM Call 12,500 -85.28 250 -77.60 n/a n/a n/a
2021-02-16 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM Call 12,500 250 n/a n/a n/a
2019-08-14 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM Call 84,900 1,116 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2018-05-15 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM Put 27,000 498 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.